Adjunct Professor of Internal Medicine
New York University School of Mrdicone
It is well understood that hypertension is the leading risk factor for cardiovascular disease. Yet we still measure and classify individuals using a technique and device, developed in the 19th century. In the past few decades, new techniques to measure blood pressure have been perfected and validated and shown to be a superior way to define risk and demonstrate benefit of treatment, namely ambulatory blood pressure measurements. Yet this test is still not reimbursed by CMS, thus limiting its availability for many patients who would benefit from the knowledge accrued from these data. It is time and long overdue for ABPM to be covered by CMS.